@article{HBSN24474,
author = {Silvia Sookoian and Carlos J. Pirola},
title = {Nonalcoholic steatohepatitis pharmacotherapy and predictors of response: dual role of aminotransferases as biosensors of metabolism and biomarkers of histological improvement},
journal = {Hepatobiliary Surgery and Nutrition},
volume = {8},
number = {4},
year = {2019},
keywords = {},
abstract = {Nonalcoholic steatohepatitis (NASH)—the severe histological form of nonalcoholic fatty liver disease (NAFLD)—is regarded as a major health problem worldwide (1,2). The disease can progress to liver cirrhosis and eventually to hepatocellular carcinoma (1,3). Treatment of NASH and NASH-fibrosis is thus increasingly being given priority in the clinical field.},
issn = {2304-389X}, url = {https://hbsn.amegroups.org/article/view/24474}
}